Costas Thomopoulos, Jana Brguljan Hitij, Tine De Backer, Eugenia Gkaliagkousi, Reinhold Kreutz, Marilucy Lopez-Sublet, Maria Marketou, Anastasia S Mihailidou, Agnieszka Olszanecka, Antoinette Pechère-Bertschi, Mariana Paula Pérez, Alexandre Persu, Federica Piani, Thenral Socrates, Katarzyna Stolarz-Skrzypek, Renata Cífková
Hypertensive disorders in pregnancy (HDP), remain the leading cause of adverse maternal, fetal, and neonatal outcomes. Epidemiological factors, comorbidities, assisted reproduction techniques, placental disorders, and genetic predisposition determine the burden of the disease. The pathophysiological substrate and the clinical presentation of HDP are multifarious. The latter and the lack of well designed clinical trials in the field explain the absence of consensus on disease management among relevant international societies...
April 12, 2024: Journal of Hypertension